http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-200101826-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c7497a891481387dff75f33501c5032
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
filingDate 1999-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5ab7dcc48be3b8fc3b902e6b95cd68a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a31f15555ff645165cb2da960c70c3c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd719eb0bb2dc283ea1905cb6937775
publicationDate 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-200101826-T2
titleOfInvention Three-phase oral contraceptive drug
abstract A contraceptive method is described, in which an estrogen and a progestogen are administered daily in a three-phase sequence for 21 days. In the first phase, a combination of estrogen and a progestogen at a low but effective contraceptive daily dosage corresponding to 0.065-0.75 norethindrone as progestogenic activity and 23-28 17a-ethinylstradiol as estrogenic activity; then, for 7-11 days, a progestogen corresponding to 0.25-1.0 mg norethindrone as progestogenic activity and estrogen in the same dosage; then, for 3-7 days, by applying a progestogen corresponding to 0.35-2.0 mg norethindrone as progestogenic activity and estrogen in the same dosage; then, for 4-8 days, a regimen is applied without applying an estrogen or a progestogen.
priorityDate 1998-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501830

Total number of triples: 21.